CLINICAL_TRIALS
research
· 2025-03-21
Clinical Trial Update: Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment [Phase 2]
Summary
This entry describes a Phase 2 clinical trial evaluating oxytocin as an add-on to psychosocial treatment to enhance social skills in schizophrenia spectrum diso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia Spectrum Disorders (SSD) | Phase 2 | Status: RECRUITING